GSK - GlaxoSmithKline PLC Stock Trading

As the FDA moves to approve multiple booster shots for all of the available Covid-19 vaccines available today, concerns are mounting as more studies are suggesting the first wave of vaccinations are waning significantly in efficacy. It’s becoming clearer that the world needs ...

Because the inflationary environment and supply chain constraints could keep the overall stock market under pressure in the near term, we think it could be wise to bet on quality dividend stocks to benefit from a steady stream of income. GlaxoSmithKline (GSK), Fortescue (FSUGY), Kronos (KRO),...

There's a big battle shaping up with several large drugmakers developing respiratory syncytial virus (RSV) vaccines. Johnson & Johnson (NYSE: JNJ) recently announced positive results from a phase 2 study of its RSV vaccine candidate. In this Motley Fool Live video recorded...